Efficacy and Safety of a Routine Early Invasive Strategy After Fibrinolysis Stratified by Glycoprotein IIb/IIIa Inhibitor Use During Percutaneous Coronary Intervention: A Pre-Specified Subgroup Analysis of the TRANSFER-AMI Randomised Controlled Trial

Study Questions:

What is the efficacy and safety of an early invasive strategy post-fibrinolysis in relation to glycoprotein (GP) IIb/IIIa inhibitor use?